Carl Borrebaeck brings experience from his time as a board member of Immunovia AB, SenzaGen AB, CB Ocean Capital AB, Alligator Bioscience AB, Clinical Laserthermia Systems AB, Scandion A/S, and commercial experience from a number of IPOs.
He has a DSc in biochemistry with a focus on molecular i